RePORT International Resources

The Colloquium Health in Motion: Infectious Diseases on the Move will bring together researchers, public health professionals, policy makers and innovators from around the world. Together, we will explore how movement of people, pathogens, vectors, environments and policies is reshaping the dynamics of infectious diseases, the resilience of health systems, and the strategies needed to respond to them. Date 15–17 November, 2026. The Colloquium will be hosted in Addis Ababa, Ethiopia

This conference will be held April 12-14, 2027 in Zaragoza, Spain.  With an overarching theme of "Committed to success for a world that can't wait," the 8th Global Forum program will cover the full spectrum of research and development and implementation, from basic and discovery research to diversify the TB vaccine pipeline through clinical research and introduction. With multiple candidates now advancing through late-stage clinical trials, we will also explore strategies to ensure new TB vaccines reach the populations that most need them and to maximize the public health impact. The program is around thematic tracks which align with the Strategic Framework for TB Vaccine Development in the Stop TB Partnership’s Global Plan to End TB 2023-2030, the EDCTP/AIGHD Global roadmap for research and development of tuberculosis vaccines, and the work underway by the WHO to develop a Global Framework to prepare for Country Introduction of New TB Vaccines for Adolescents and Adults.

Webinar #1. Inclusion and Accessibility in the Lab Environment (IDEAS): This webinar will focus on becoming a researcher in academic medicine and hearing from researchers with disabilities on how they have navigated and experienced graduate education, training, and beyond, and from faculty on navigating and self-advocating through challenges in both the classroom and lab. Topics will include applying for graduate school and postdoctoral positions, selecting faculty advisors and mentors, unique challenges in the classroom and lab environment, and sources of institutional and community support. Webinar #2. Using Inclusive Language in Scholarly Writing: A Roundtable Discussion: This webinar provided information and guidance on the use of language that is inclusive and accurate in its depiction of identity, lived experiences, health and well-being, and health outcomes. Panelists discussed the principles of using inclusive language across their roles as scholars, authors, reviewers, and editors and offered practical strategies for writing that aligns with inclusive language best practices and welcomes the diversity of all people and their identities. AAMC account access is required.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. Consult Part 2. Section III.1 Eligible Organizations for more information. Please refer to the website for detail announcement and key dates.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. Consult Part 2. Section III.1 Eligible Organizations for more information.   Please refer to the website for detail announcement and key dates.

NOTE: 2025 application cycle is closed. Check the website again for 2026 updates. This track will aim to strengthen prevention, preparedness and response capacities in the face of future health crises, focusing on the priority emerging infectious diseases identified in the 2024 call: respiratory viruses, viral haemorrhagic fevers and arboviruses. The expected projects should adopt an interdisciplinary approach and contribute to advancing research in the service of public health. This call for proposals targets the three founding strands of the PEPR MIE: Section 1: Accelerating the acquisition of fundamental knowledge on emerging infectious diseases Section 2: Promoting innovation and developing new treatments, vaccines and other prevention, diagnostic and surveillance tools for emerging infectious diseases Section 3: Enabling public policies and society to cope with epidemic crises

This is a children's book in Portuguese (Brazil) on TB.

ASLM is a pan-African professional body that advocates for the critical role and needs of laboratory medicine and networks throughout Africa. These podcast topics touch upon biosafety and security, budgets, inclusivity, antimicrobial resistance, resource mobilization, and lab staff training.

African Society for Laboratory Medicine has archived many of its previous webinars on best practices in lab procedures related to monitoring and evaluation, multisectoral collaboration, and funding.

Tuberculosis (TB) remains a major public health challenge. The World Health Organization (WHO) recommends three classes of nucleic acid amplification tests (NAATs) for initial TB detection: near point-of-care, low-complexity, and medium-complexity platforms. While this expanded toolkit improves access to rapid diagnosis, it also adds complexity. Implementing a diversified diagnostic network requires data-driven planning and careful matching of tools to population needs. Close collaboration between National TB Programs (NTPs) and National TB Reference Laboratories (NTRLs) is essential to ensure that diagnostic strategies are aligned with network capacity and priorities. Decisions must balance cost, coverage, and equitable access to services. A comprehensive, costed implementation plan should guide all stages of deployment, from infrastructure and workforce capacity to training, data systems, and monitoring. This guide distils key insights and practical lessons from South Africa, Kenya, and Uganda, where multiple molecular diagnostic platforms have been successfully implemented to strengthen TB detection and expand access to timely diagnosis.

This resource provides a thorough overview of how to do a robust literature review. It includes text and videos from other sources.

The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions. Please refer to the websites for various funding opportunities and key dates for application.

The 2027 ASM Microbe meeting will continue the newly re-envisioned tri-located structure launched in 2026, bringing together 3 specialized meetings under the ASM Microbe umbrella: ASM Health Meeting, ASM Applied and Environmental Microbiology Meeting, ASM Mechanism Discovery Meeting. Together, these meetings provide comprehensive access to the latest advances across the microbial sciences while fostering meaningful cross-disciplinary collaboration. It will be held June 22-25, 2027 in Chicago

The Pediatric Assembly of the American Thoaracic Society (ATS) sponsored this webinar as part of its Virtual International Pediatric Pulmonary Network clinical case series. The first case was presented and discussed by Tony Onyia, MD, University of Nigeria Teaching Hospital, Dept of Pediatrics, Ituku-Ozalla Enugu Nigeria. The second case was presented by Birce Sunman, MD, Gülhane Training and Research Hospital, Ankara and discussed by Prof Hasan Yüksel, Celal Bayar University, School of Medicine, Dept of Pediatric Pulmology, Manisa and Assoc. Prof. Zafer Dökümcü, Ege University, School of Medicine, Dept of Pediatric Surgery, Izmir, Türkiye. The session is chaired by Prof. Joy Eze, University of Nigeria Teaching Hospital, Dept. Of Pediatrics, Ituku-Ozalla Enugu Nigeria and Prof. Özge Yılmaz from Manisa Celal Bayar University, School of Medicine, Dept. Of Pediatric Allergy, Manisa, Türkiye.

ATS recorded video (1 hour 15 min) - Equity in Global Health Research Webinar Recording November 9, 2023

Donations are a contribution, grant, or payment in cash or in kind, made by Amgen to a not-for-profit and/or tax exempt organization without expectation of something in return other than customary donor recognition of incidental value. Amgen may make only donations to Qualified Recipients as set forth in the Eligibility Criteria section, to further an educational, scientific or other charitable purpose. As part of Amgen's mission to serve patients, Amgen makes donations to qualified members of the U.S. healthcare community for the following purposes: The support of science, technology, medicine, healthcare or education; or Education of the public on disease states, medical conditions, science or technology; or In furtherance of other genuine philanthropic and charitable purposes that are consistent with Amgen's scientific and disease-state interests.

European Respiratory Society (ERS) Long-Term Research Fellowships support researchers and clinicians in the early stages of their careers to carry out basic, translational or clinical research projects lasting between 6–24 months. Fellowship recipients conduct projects at research institutions outside of their home country, enabling fellows to access and learn research techniques that are not available at their home institutions. Long-term fellowships are awarded annually based on scientific merit as well as the skills and experience that fellows can bring to the host institution.

A career development fellowship sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC), this program supports awarded fellows from all 10 UC campuses as well as 22 affiliated international sites across 18 countries. UCGHI manages and supports the GloCal Health Fellowship.

The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission.

The ANRS Emerging Infectious Diseases, an autonomous agency of Inserm, supports research to provide scientific responses to infectious diseases in times of crisis and over the long term. It animates, coordinates, evaluates and finances research on HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases such as Covid-19, viral hemorrhagic fevers or arboviruses. It covers all areas of research: basic, translational and clinical research, research in public health and human and social sciences. The agency is developing a global health approach according to the One Health approach, which focuses on the links between human health, animal health and the environment. It thus strengthens France's response in the event of a crisis. The agency is part of an international effort to fight epidemics, in particular in close coordination with Europe and with a network of partners in low- and middle-income countries.